A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia

Clinical trial NCT04043104 · COMPLETED

Trial details

NCT number: NCT04043104
Sponsor: MeiraGTx UK II Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Radiation-Induced Parotid Gland Hypofunction Xerostomia Due to Radiotherapy Head and Neck Cancer

Start date: 2019-06-30
Primary completion: 2023-03-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.